πŸ‡ΊπŸ‡Έ FDA
Patent

US 10993834

Lacrimal system drug delivery device

granted A61KA61K9/0048A61P

Quick answer

US patent 10993834 (Lacrimal system drug delivery device) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K9/0048, A61P, A61P11/02, A61P27/02